Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Its product candidates ...

Merck & Co is reportedly on the verge of acquiring EyeBio, an eye-drug company, for a sum of $1.3 billion. This acquisition ...

We believe that the pharmaceuticals bellwether Johnson & Johnson (NYSE: JNJ) is currently a better pick over its peer Merck (NYSE: MRK).

Such an acquisition would steer a company known for its cancer immunotherapy, Keytruda, into the multibillion-dollar eye-drug ...

Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New ...

Mrs. Montano Owned and Operated Acceleron, Inc., with her former husband Donald Montano, in East Granby for many years prior to her retirement. She was a member of the Jupiter Tennis Club and was a ...

He was employed as a laser welder at Acceleron, Inc. of East Granby and was also employed for 18 years at Town Line Pizza in Simsbury and was treated like a member of the Psanis family. He was a ...

Merck & Co. restocked its cabinet of eye treatments with the purchase of Eyebiotech Ltd. for as much as $3 billion, a move to ...

Princeton, New Jersey Saturday, May 25, 2024, 17:00 Hrs [IST] ...

MSD has confirmed a $3 billion takeover deal for ophthalmology biotech EyeBio and its drug candidate for diabetic macular ...